SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-177871
Filing Date
2021-06-01
Accepted
2021-06-01 08:01:02
Documents
15
Period of Report
2021-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d190382d8k.htm   iXBRL 8-K 27909
2 EX-1.1 d190382dex11.htm EX-1.1 170098
3 EX-5.1 d190382dex51.htm EX-5.1 9086
7 GRAPHIC g190382g93r20.jpg GRAPHIC 4085
  Complete submission text file 0001193125-21-177871.txt   393982

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20210601.xsd EX-101.SCH 3086
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20210601_lab.xml EX-101.LAB 18906
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20210601_pre.xml EX-101.PRE 11873
8 EXTRACTED XBRL INSTANCE DOCUMENT d190382d8k_htm.xml XML 3509
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 21983112
SIC: 2834 Pharmaceutical Preparations